ArticleThe Journal of pathology2016

Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.

Ofrat Beyar-Katz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.